Colgate-Palmolive (NYSE:CL) PT Raised to $90.00
Colgate-Palmolive (NYSE:CL – Get Free Report) had its price objective lifted by equities research analysts at JPMorgan Chase & Co. from $88.00 to $90.00 in a research note issued on Thursday, Benzinga reports. The brokerage presently has an “overweight” rating on the stock. JPMorgan Chase & Co.‘s price target would suggest a potential upside of […]
More Stories
SB Financial Group, Inc. (NASDAQ:SBFG) Short Interest Down 34.5% in December
SB Financial Group, Inc. (NASDAQ:SBFG – Get Free Report) saw a large decrease in short interest in the month of...
Musk, Ramaswamy Defend Foreign Worker Visas Amid Social Media Backlash
By Jacob Burg After Elon Musk and Vivek Ramaswamy made posts on the social platform X this week endorsing an...
Nauticus Robotics, Inc. (NASDAQ:KITT) Sees Large Drop in Short Interest
Nauticus Robotics, Inc. (NASDAQ:KITT – Get Free Report) saw a significant decline in short interest during the month of December....
Sharp Co. (OTCMKTS:SHCAY) Short Interest Update
Sharp Co. (OTCMKTS:SHCAY – Get Free Report) was the recipient of a significant decrease in short interest in December. As...
Mitsui O.S.K. Lines, Ltd. (OTCMKTS:MSLOY) Sees Large Decrease in Short Interest
Mitsui O.S.K. Lines, Ltd. (OTCMKTS:MSLOY – Get Free Report) was the recipient of a significant drop in short interest in...
Kidney Stones: Symptoms, Causes, Treatments, and Natural Approaches
By Terri Ward, Medically Reviewed Jimmy Almond, M.D. Kidney stones, also known as nephrolithiasis or urolithiasis, are small, hard mineral...